Detection of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on imatinib-Reference-Cited by-同舟云学术

Detection of BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on imatinib

Published:2013-11 Issue:6 Volume:18 Page:328-333
ISSN:1607-8454
Container-title:Hematology
language:en
Short-container-title:Hematology

Author:

Chahardouli Bahram¹,Zaker Farhad²,Mousavi Seied Asadollah³,Saffari Zeinab³,Nadali Fatemeh⁴,Ostadali Mohammadreza³,Ghadimi Habibeh³,Alimoghaddam Kamran³,Ghavamzade Ardeshir³,Rostami Shahrbano³

Affiliation:

1. Department of HematologySchool of Allied Medical Sciences, Tehran University of Medical Sciences, Iran; and Hematology, Oncology, and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Iran

2. Department of HematologySchool of Allied Medical Sciences, Tehran University of Medical Sciences, Iran; and Cellular and Molecular Research Center, Tehran University of Medical Sciences, Iran

3. HematologyOncology, and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Iran

4. Department of HematologySchool of Allied Medical Sciences, Tehran University of Medical Sciences, Iran

Publisher

Informa UK Limited

Subject

Hematology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1179/1607845413Y.0000000095

Reference31 articles.

1. Applying the discovery of the Philadelphia chromosome

2. Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet

3. Imatinib Mesylate — A New Oral Targeted Therapy

4. Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

5. Long-term prognostic significance of early molecular response to imatinib in newly diagnosed chronic myeloid leukemia: an analysis from the International Randomized Study of Interferon and STI571 (IRIS)

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of the Efficacy Among Nilotinib, Dasatinib, Flumatinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients: A Real-World Multi-Center Retrospective Study;Clinical Lymphoma Myeloma and Leukemia;2024-06

2. Pathogenic variants causing ABL1 malformation syndrome cluster in a myristoyl-binding pocket and increase tyrosine kinase activity;European Journal of Human Genetics;2020-11-22

3. Evaluation of Molecular Response to Imatinib Mesylate Treatment in Iranian Patients With Chronic Myeloid Leukemia;Clinical Lymphoma Myeloma and Leukemia;2020-01

4. Genetic Variants Involved in Intracellular Mechanisms of Chemoresistance to Anticancer Drugs Due to Changes in the Effect on Their Molecular Targets;eLS;2013-12-08